Panacea Life Sciences Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 18 Sep 23 | BuyUS$4,730 | Leslie Buttorff | Individual | 20,000 | US$0.24 | |
| 09 Jun 23 | BuyUS$1,298 | Leslie Buttorff | Individual | 3,000 | US$0.43 | |
| 23 May 23 | BuyUS$3,324 | Leslie Buttorff | Individual | 6,500 | US$0.52 | |
| 09 May 23 | BuyUS$867 | Leslie Buttorff | Individual | 2,300 | US$0.38 | |
| 08 May 23 | BuyUS$6,280 | Leslie Buttorff | Individual | 13,000 | US$0.49 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| General Public | 217,625 | 1.23% |
| Public Companies | 3,250,573 | 18.4% |
| Private Companies | 4,047,054 | 22.9% |
| Individual Insiders | 10,130,100 | 57.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 8,657,526 | US$1.6m | 464% | no data | |||
| 4,047,054 | US$764.9k | 0% | no data | |||
| 3,250,573 | US$614.4k | 0% | no data | |||
| 796,957 | US$150.6k | 0% | no data | |||
| 607,868 | US$114.9k | 97.4% | no data | |||
| 67,749 | US$12.8k | 282% | no data |